Davis's Drug Guide
vernakalant
General
Canada-Approved Medicine
This monograph describes a medication approved for use in Canada by the Therapeutic Products Directorate, a division of Health Canada’s Health Products and Food Branch. The medication is not approved by the United States Food and Drug Administration; however, a similar formulation carrying a different generic or brand name might be available in the US.
Pronunciation:
ver- nak-a-lant
Trade Name(s)
- Brinavess
Ther. Class.
(class III)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Vernakalant." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580144/9/vernakalant.
Vallerand AHA, Sanoski CAC, . Vernakalant. Davis's Drug Guide. F.A. Davis Company; 2025. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580144/9/vernakalant. Accessed October 18, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Vernakalant. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580144/9/vernakalant
Vallerand AHA, Sanoski CAC, . Vernakalant [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 October 18]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580144/9/vernakalant.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - vernakalant
ID - 3580144
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/3580144/9/vernakalant
PB - F.A. Davis Company
ET - 19
DB - Emergency Central
DP - Unbound Medicine
ER -
